Cyano Precursor Synthesis for Tau PET Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing compounds for selective detection of Tau aggregates, such as those associated with Alzheimer's disease, are inefficient, costly, and require multiple purification steps, with poor solubility issues and low yields due to the use of nitro precursors in ethanol and acetonitrile mixtures.
Innovation Solution
A method involving reacting a compound of formula II with a 18F fluorinating agent, followed by high-performance liquid chromatography (HPLC) using a mobile phase of ethanol and water, which simplifies the process by eliminating the need for solid phase extraction and reducing the number of chromatographic steps, thereby improving yield and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If nitro precursors are used in ethanol and acetonitrile mixtures for purification, then the compound can be purified, but the precursor has poor solubility and requires multiple purification steps
Solution Approach 1:
The patent changes the chemical structure of the precursor by replacing the nitro group with a cyano group. This parameter change in molecular structure fundamentally alters the solubility properties, allowing the precursor to be highly soluble in ethanol and acetonitrile mixtures, thereby eliminating precipitation issues and enabling single-step purification without requiring multiple complex purification steps
Solution Approach 2:
The invention extracts or removes the problematic nitro group functionality from the precursor molecule and replaces it with a cyano group. This extraction of the problematic functional group eliminates the solubility issues that necessitated multiple purification steps, while maintaining the compound's ability to be purified to high quality through a single HPLC step
2Manufacturing precision
If multiple purification steps including solid phase extraction are used, then the compound purity is improved, but the preparation time and cost increase
Solution Approach 1:
By changing the precursor structure from nitro to cyano, the patent enables the use of a single HPLC purification step with ethanol/water mobile phase to achieve high purity (>95%). This parameter change in precursor structure eliminates the need for time-consuming solid phase extraction and multiple chromatographic steps, reducing preparation time while maintaining high compound purity
Solution Approach 2:
The invention merges the purification function into a single HPLC step that simultaneously achieves both purification and formulation for PET imaging. The cyano precursor's solubility properties allow the HPLC mobile phase (ethanol/water) to serve dual purposes: purifying the compound and preparing it in a diagnostically acceptable form, eliminating the need for separate solid phase extraction and reformulation steps
3Productivity
If nitro precursors are used, then the compound can be synthesized, but the yield is low due to poor solubility and precipitation
Solution Approach 1:
The patent changes the precursor's functional group from nitro to cyano, which fundamentally improves the quantity of substance that can be dissolved in the reaction and purification media. The cyano precursor exhibits high solubility in ethanol and acetonitrile, allowing larger quantities to be used without precipitation, thereby increasing the synthesis yield from 26.1% to significantly higher values
Solution Approach 2:
The invention creates a modified version (copy) of the nitro precursor by replacing the nitro group with a cyano group. This copied structure maintains the essential functional properties needed for the radiolabeling reaction to produce the Tau imaging compound, while eliminating the solubility and yield problems associated with the original nitro precursor
4Speed
If automated microwave methods are used, then the synthesis speed is improved, but the method is only partially automated and requires manual intervention
Solution Approach 1:
By changing the precursor from nitro to cyano, the patent enables complete automation of the synthesis process. The improved solubility characteristics allow the entire workflow including HPLC purification to be automated without manual intervention for sample preparation or cartridge handling, achieving full automation while maintaining fast synthesis speed through microwave heating
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method results in a higher yield and radiochemical purity of the compound, reducing preparation time and costs, while maintaining diagnostic acceptability and allowing for larger quantities of precursor use without precipitation, enabling effective detection of Tau aggregates using PET imaging.
Implementation Method 1
subjecting the resultant compound of the formula I to high-performance liquid chromatography (HPLC) using a mobile phase comprising a mixture of ethanol and water
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a novel method of preparing a compound of the formula I. Diagnostic compositions and their use in the selective detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease (AD) and other tauopathies, for example, using Positron Emission Tomography (PET) imaging are also disclosed.